BBH.US VanEck Biotech ETF
- Total assets
- 536M
- Expense ratio
- 0.33%
- Dividend yield
- 0.38%
- 1-year return
- +39.68%
- Holdings
- 25
- Since
- 2011
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does BBH.US invest in?
- Mostly US stocks (99.3%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 39.6% of the fund
Asset allocation
- US stocks 99.3%
- Cash 0.1%
Top holdings
- Amgen Inc 17.37%
- Gilead Sciences Inc 13.69%
- Vertex Pharmaceuticals Inc 8.52%
- Moderna Inc 7.59%
- Regeneron Pharmaceuticals Inc 7.11%
VanEck Biotech ETF performance
Sharpe ratio 1.04- This year
- +35.32%
- 1 year
- +39.68%
- 3 years
- +21.00%
- 5 years
- +7.01%
Volatility 19.1% over 1 year and 16.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
BBH.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Full fund profileVanEck Biotech ETF top holdings
73.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Amgen Inc AMGN.US | Healthcare | United States | 17.37% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 13.69% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 8.52% |
| Moderna Inc MRNA.US | Healthcare | United States | 7.59% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 7.11% |
| argenx NV ADR ARGX.US | Healthcare | United States | 4.58% |
| IQVIA Holdings Inc IQV.US | Healthcare | United States | 4.47% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 3.89% |
| Natera Inc NTRA.US | Healthcare | United States | 3.54% |
| BeiGene Ltd BGNE.US | Healthcare | United States | 3.15% |
The 10 largest of 25 holdings.
BBH.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
BBH.US regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 78.7B- Big cap46.6%
- Medium cap43.8%
- Small cap7.3%
VanEck Biotech ETF fund profile
- Fund name
- VanEck Biotech ETF
- Ticker
- BBH.US
- Exchange
- USA Stocks
- Issuer
- VanEck
- Fund website
- vaneck.com/funds/BBH.aspx
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Dec 20, 2011
- Trading currency
- USD
- Expense ratio
- 0.33%
- Annual turnover
- 0.2%
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.